BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 16737912)

  • 1. Derivative (1;7)(q10;p10) in multiple myeloma. A sign of therapy-related hidden myelodysplastic syndrome.
    Ishii Y; Hsiao HH; Sashida G; Ito Y; Miyazawa K; Kodama A; Ohyashiki JH; Ohyashiki K
    Cancer Genet Cytogenet; 2006 Jun; 167(2):131-7. PubMed ID: 16737912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Additional cytogenetic changes and previous genotoxic exposure predict unfavorable prognosis in myelodysplastic syndromes and acute myeloid leukemia with der(1;7)(q10;p10).
    Hsiao HH; Sashida G; Ito Y; Kodama A; Fukutake K; Ohyashiki JH; Ohyashiki K
    Cancer Genet Cytogenet; 2006 Mar; 165(2):161-6. PubMed ID: 16527611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [der(1;7) (q10;p10) in three patients with malignant hematologic disorders].
    Yokoo H; Okada Y; Tominaga K; Tsuji M; Takagi T; Maseki N; Sakurai M; Kaneko Y
    Rinsho Ketsueki; 1992 Dec; 33(12):1829-33. PubMed ID: 1479694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does MDS with der(1;7)(q10;p10) constitute a distinct risk group? A retrospective single institutional analysis of clinical/pathologic features compared to -7/del(7q) MDS.
    Slovak ML; O'Donnell M; Smith DD; Gaal K
    Cancer Genet Cytogenet; 2009 Sep; 193(2):78-85. PubMed ID: 19665067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unbalanced translocation der(1;7)(q10;p10) defines a unique clinicopathological subgroup of myeloid neoplasms.
    Sanada M; Uike N; Ohyashiki K; Ozawa K; Lili W; Hangaishi A; Kanda Y; Chiba S; Kurokawa M; Omine M; Mitani K; Ogawa S
    Leukemia; 2007 May; 21(5):992-7. PubMed ID: 17315020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myeloid neoplasms secondary to plasma cell myeloma: an intrinsic predisposition or therapy-related phenomenon? A clinicopathologic study of 41 cases and correlation of cytogenetic features with treatment regimens.
    Reddi DM; Lu CM; Fedoriw G; Liu YC; Wang FF; Ely S; Boswell EL; Louissaint A; Arcasoy MO; Goodman BK; Wang E
    Am J Clin Pathol; 2012 Dec; 138(6):855-66. PubMed ID: 23161720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Chromosomal structural changes in patients with myelodysplastic syndrome].
    Yu Y; Liu XP; Liu SH; Yu MH; Zhang Y; Xiao ZJ
    Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(38):2693-7. PubMed ID: 18167247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unbalanced whole-arm translocation der(5;19)(p10;q10) is a novel and recurrent cytogenetic aberration in myelodysplastic syndrome.
    Yamamoto K; Okamura A; Katayama Y; Shimoyama M; Matsui T
    Leuk Res; 2009 Mar; 33(3):377-83. PubMed ID: 18829109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Multiple myeloma preceding myelodysplastic syndrome with eosinophilia and der (1;7)].
    Matano S; Kobayashi K; Nakamura S; Yoshida T
    Rinsho Ketsueki; 1994 Nov; 35(11):1310-4. PubMed ID: 7823398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5q- syndrome-like features as the first manifestation of myelodysplastic syndrome in a patient with an unbalanced whole-arm translocation der(5;19)(p10;q10).
    Ureshino H; Kizuka H; Kusaba K; Sano H; Nishioka A; Shindo T; Kubota Y; Ando T; Kojima K; Kimura S
    Int J Hematol; 2017 May; 105(5):692-696. PubMed ID: 27914067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deletion of 5q31 and 7q31 in patients with stable melphalan treated multiple myeloma.
    Amiel A; Yukla M; Yogev S; Manor Y; Fejgin MD; Lishner M
    Cancer Genet Cytogenet; 2004 Jul; 152(1):84-7. PubMed ID: 15193449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Three cases of multiple myeloma developing into melphalan-related chronic myelomonocytic leukemia.
    Ueki K; Sato S; Tamura J; Sawamura M; Murakami H; Naruse T; Tsuchiya J
    J Med; 1991; 22(3):157-61. PubMed ID: 1770323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sole abnormalities of chromosome 7 in myeloid malignancies: spectrum, histopathologic correlates, and prognostic implications.
    Hussain FT; Nguyen EP; Raza S; Knudson R; Pardanani A; Hanson CA; Van Dyke D; Tefferi A
    Am J Hematol; 2012 Jul; 87(7):684-6. PubMed ID: 22565657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Secondary myelodysplastic syndrome in multiple myeloma--a study of nine patients with an attempt to detect myeloma patients at risk.
    Mittelman M; Lewinski UH; Weiss H; Cohen AM; Djaldetti M; Pick AI
    Haematologia (Budap); 1994; 26(2):67-74. PubMed ID: 7890264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leukemic transformation associated with massive hyperdiploidy in myelodysplastic syndrome (MDS) with der(1;7)(q10;p10): a novel case study.
    Lim G; Oh SH; Choi JR; Lee HJ; Suh JT; Yoon HJ; Lee S; Lee WI; Park TS
    Leuk Res; 2010 Aug; 34(8):e208-9. PubMed ID: 20299095
    [No Abstract]   [Full Text] [Related]  

  • 16. Derivative (1;7)(q10;p10) in two patients with myelodysplastic syndrome after autologous haematopoietic cell transplantation.
    Papaioannou G; Batsis I; Iordanidis F; Vadikoliou C; Kaloyannidis P; Anagnostopoulos A; Athanasiadou A
    Hematol Oncol; 2011 Sep; 29(3):161-3. PubMed ID: 21922511
    [No Abstract]   [Full Text] [Related]  

  • 17. Conventional and molecular cytogenetic findings of myelodysplastic syndrome patients.
    Yilmaz Z; Sahin FI; Kizilkilic E; Karakus S; Boga C; Ozdogu H
    Clin Exp Med; 2005 Jul; 5(2):55-9. PubMed ID: 16096854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chromosomal aberrations in bone marrow mesenchymal stroma cells from patients with myelodysplastic syndrome and acute myeloblastic leukemia.
    Blau O; Hofmann WK; Baldus CD; Thiel G; Serbent V; Schümann E; Thiel E; Blau IW
    Exp Hematol; 2007 Feb; 35(2):221-9. PubMed ID: 17258071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluorescence in situ hybridization analysis of 110 hematopoietic disorders with chromosome 5 abnormalities: do de novo and therapy-related myelodysplastic syndrome-acute myeloid leukemia actually differ?
    Lessard M; Hélias C; Struski S; Perrusson N; Uettwiller F; Mozziconacci MJ; Lafage-Pochitaloff M; Dastugue N; Terré C; Brizard F; Cornillet-Lefebvre P; Mugneret F; Barin C; Herry A; Luquet I; Desangles F; Michaux L; Verellen-Dumoulin C; Perrot C; Van den Akker J; Lespinasse J; Eclache V; Berger R;
    Cancer Genet Cytogenet; 2007 Jul; 176(1):1-21. PubMed ID: 17574959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and toxicity of low-dose melphalan in myelodysplastic syndromes and acute myeloid leukemia with multilineage dysplasia.
    Robak T; Szmigielska-Kapłon A; Urbańska-Ryś H; Chojnowski K; Wrzesień-Kuś A
    Neoplasma; 2003; 50(3):172-5. PubMed ID: 12937849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.